Labcorp Holdings Inc.: Labcorp reported $13.9517 billion in 2025 revenue. Labcorp trades as LH on NYSE.
Labcorp Holdings Inc.: Key Facts
- Founded: 1995 by Formed through merger of Roche Biomedical Laboratories and National Health Laboratories; key historical leaders include James Powell (National Health Laboratories) and David King (post-merger CEO).
- Headquarters: Burlington, North Carolina.
- CEO: Adam H. Schechter.
- Latest annual revenue: $14.0B.
- Employees: 71,000.
Labcorp makes money from diagnostic testing ordered by physicians, hospitals, employers, payers, and patients, plus biopharma laboratory services such as central lab work, early development, companion diagnostics, and clinical-trial support. Volume, reimbursement rates, test mix, logistics efficiency, and laboratory automation drive profitability.
Labcorp generated $13.9517 billion in 2025 revenue, up from $13.0089 billion in 2024, with net earnings attributable to Labcorp rising to $876.5 million. Diagnostics remained the larger segment, while Biopharma Laboratory Services added growth tied to pharmaceutical and biotech demand.
Quest Diagnostics is the cleanest peer, but Labcorp also competes with hospital outreach labs, academic medical centers, specialty diagnostic companies, and CRO-linked service providers. Labcorp differentiates by combining routine testing density with biopharma laboratory capabilities after the Fortrea spin-off clarified the portfolio.
Labcorp's outlook depends on specialty testing, hospital and health-system partnerships, automation, payer discipline, and the ability to convert scientific capabilities into tests that improve clinical decisions.
